Funding Opportunities

The NCI Division of Cancer Prevention funds new research in cancer prevention, detection, screening, interception, and symptom management. We also fund programs to train people for careers in research. Explore current open funding opportunities here and streamline your search by using keyword or type of funding.

Information about the funding opportunity announcements that align with the efforts of the Cancer Moonshot^SM can be found here: https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/funding.

Notice of Funding Opportunities

Title	Announcement Number	Activity Code	Clinical Trials Status	Expiration Date Sort descending	Program Official
Notice of Special Interest (NOSI): Research on the Etiology, Early Detection, Screening and Prevention of Early-Onset Colorectal Cancer	NOT-CA-23-018			09/08/2024	Gary Della'Zanna, D.O., M.Sc.
Mechanisms that Impact Cancer Risk after Bariatric Surgery	PAR-21-332 (R21 Clinical Trial Not Allowed)	R21	Clinical Trial Not Allowed	09/08/2024	Edward Sauter, M.D., Ph.D.
Notice of Special Interest (NOSI): Dietary Effects on Nutrient Sensing Pathways in Tumor Etiology and Prevention	NOT-CA-21-121			09/08/2024	Sharon Ross, Ph.D., M.P.H.
Notice of Special Interest (NOSI): Mechanisms Driving Obesity and Prostate Cancer Risk	NOT-CA-23-089			09/08/2024	Edward Sauter, M.D., Ph.D.
Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research	RFA-CA-24-009 (R33 Clinical Trial Not Allowed)	R33	Clinical Trial Not Allowed	10/02/2024	Guillermo Marquez, Ph.D.
Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research	RFA-CA-24-008 (R61 Clinical Trial Not Allowed)	R61	Clinical Trial Not Allowed	10/02/2024	Guillermo Marquez, Ph.D.
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research	RFA-CA-24-012 (R01 Clinical Trial Optional)	R01	Clinical Trial Optional	10/02/2024	Guillermo Marquez, Ph.D.
Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research	RFA-CA-24-014 (P50 Clinical Trial Optional)	P50	Clinical Trial Optional	10/02/2024	Guillermo Marquez, Ph.D.
Revision Applications for Incorporation of Novel NCI- Supported Technology to Accelerate Cancer Research	RFA-CA-24-013 (U01 Clinical Trial Optional)	U01	Clinical Trial Optional	10/02/2024	Guillermo Marquez, Ph.D.
Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research	PAR-21-330 (U01 Clinical Trial Not Allowed)	U01	Clinical Trial Not Allowed	10/12/2024	Claire Zhu, Ph.D.